Adalimumab was more effective in the patients with bio-naive and early Crohn's disease

被引：0
|
作者：
Hisamatsu, T. [1 ]
Matsuoka, K. [1 ]
Naganuma, M. [2 ]
Miyoshi, J. [1 ,3 ]
Inoue, N. [4 ]
Yajima, T. [1 ]
Mizuno, S. [1 ]
Saigusa, K. [1 ]
Nakazato, Y. [1 ]
Mori, K. [1 ]
Takeshita, K. [1 ]
Nanki, K. [1 ]
Kiyohara, H. [1 ]
Iwao, Y. [4 ]
Ogata, H. [2 ]
Kanai, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan
[2] Keio Univ, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan
[3] Tokyo Dent Univ, Ichikawa Gen Hosp, Dept Internal Med, Ichikawa, Japan
[4] Keio Univ, Ctr Prevent Med, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60689-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P569
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [1] Treatment Persistence Among Bio-naive Patients with Crohn's Disease Initiated on Ustekinumab and Adalimumab
    Pilon, Dominic
    Ding, Zhijie
    Manceur, Ameur M.
    Muser, Erik
    Zhdanava, Maryia
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S328 - S329
  • [2] Treatment persistence among bio-naive patients with Crohn's disease initiated on ustekinumab or adalimumab
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur M.
    Muser, Erik
    Lefebvre, Patrick
    Holiday, Christopher
    Lafeuille, Marie-Helene
    Pilon, Dominic
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (04) : 533 - 543
  • [3] PERSISTENCE AND DOSE TITRATION AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB OR ADALIMUMAB
    Pilon, Dominic
    Ding, Zhijie
    Manceur, Ameur M.
    Zhdanava, Maryia
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Lefebvre, Patrick
    GASTROENTEROLOGY, 2022, 162 (07) : S415 - S415
  • [4] Long-Term Persistence to Ustekinumab and Adalimumab Among Bio-Naive Patients With Crohn's Disease
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur M.
    Kachroo, Sumesh
    Holiday, Christopher
    Zhao, Ruizhi
    Izanec, James
    Pilon, Dominic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S571 - S572
  • [5] Comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn's Disease patients
    Biscanin, A.
    Tomasic, V.
    Babic, F.
    Cacic, P.
    Kordej, D. Ogresta
    Hrabar, D.
    Kralj, D.
    Dorosulic, Z.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 695 - 695
  • [6] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    GASTROENTEROLOGY, 2023, 164 (04) : S47 - S47
  • [7] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S37 - S37
  • [8] Infliximab response associates with radiologic findings in bio-naive Crohn's disease
    Yueying, Chen
    Jing, Feng
    Qi, Feng
    Jun, Shen
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5247 - 5257
  • [9] Effectiveness and safety of ustekinumab in bio-naive Crohn's disease patients: a multicentre observational retrospective study
    Delgado Teresa, Valdes
    Martin Raul, Olmedo
    Marisa, Iborra
    de Guise Claudia, Herrera
    Esteban, Fuentes-Valenzuela
    Luigi, Melcarne
    Ma Mar, Martin-Rodriguez
    Casso Lilyan, Kolle
    Parga Luisa, De Castro
    Diaz Angel, Ponferrada
    Lidon Raquel, Vicente
    Marcos Noemi, Mancenido
    Jimenez Benito, Velayos
    Saez Marta, Lazaro
    Cauce Beatriz, Lopez
    Gismero Francisco, Mesonero
    Pau, Gilabert Alvarez
    Federico, Arguelles-Arias
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [10] Effectiveness and safety of Adalimumab Biosimilars in Bio-naive patients with Inflammatory Bowel Disease: The Galician experience
    Villaamil, P. Vega
    Rey, M. T. Vazquez
    Rey, I. Baston
    Galego, M. Ayude
    Campos, A. Carmona
    Lopez, A. M. Baz
    Arriero, G. Molina
    Barcia, M. J. Ruiz
    Exposito, C. Regueiro
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1622 - I1622
12345